GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹163 Cr | ₹170 Cr | ₹84 Cr | ₹88 Cr | ₹74 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹163 Cr |
Mar2024 | ₹170 Cr |
Mar2023 | ₹84 Cr |
Mar2022 | ₹88 Cr |
Mar2021 | ₹74 Cr |
How is Deferred Tax Assets / Liabilities of GLAND PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹163 Cr | -4.09 | |
Mar2024 | ₹170 Cr | 101.52 | |
Mar2023 | ₹84 Cr | -4.05 | |
Mar2022 | ₹88 Cr | 18.79 | |
Mar2021 | ₹74 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹32,492.8 Cr | 1.8% | -1.8% | 0.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,667.0 Cr | 1.2% | -4.2% | -5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,697.0 Cr | 3% | -9.1% | 31.5% | Stock Analytics | |
CIPLA | ₹126,365.0 Cr | 4.1% | 5.5% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,639.0 Cr | 1.1% | 4.3% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,479.0 Cr | 3.7% | 0.1% | -7.4% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 1.8% |
-1.8% |
0.7% |
SENSEX | 1.8% |
-1.7% |
2.9% |
You may also like the below Video Courses